Modernizing FDA's Supplement Industry Regulation Mapped Out In Five-Point Plan
Commissioner Scott Gottlieb announces FDA's plan for policy changes to implement "one of the most significant modernizations of dietary supplement regulation and oversight in more than 25 years." Plan includes steps to ensure its regulatory framework is flexible enough to adequately evaluate product safety while also promoting innovation, particularly finalizing NDI notifications guidance and fostering submissions of the notifications.
You may also be interested in...
AHPA releases guidance for tea and infusion products on regulatory and liability implications as a result of increasing Prop 65 lawsuits; CHPA files citizen petition urging FDA to act on a CBD pathway; PEW pushes for stronger supplement oversight; and more.
Nonprofit advocacy group says one third of echinacea and turmeric supplements it tested contained ingredients in amounts lower than labeled or elevated levels of lead or bacteria. Industry groups say CR used "arbitrary" standards based on preconceived, critical view of US supplement regulation.